References
- Wooley PH, Schwarz EM. Aseptic loosening. Gene Therapy 2004;11:402–7.
- Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT. Osteolysis: basic science. Clin Orthop 2001;393:71–7.
- Xu JW, Li TF, Partsch G, Ceponis A, Santavirta S, Konttinen YT. Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR). Scand J Rheumatol i998;27:363–7.
- Konttinen YT, Waris V, Xu JW, Jiranek WA, Sorsa T, Virtanen I, et al. Transforming growth factor-beta 1 and 2 in the synovial- like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 1997;24:694–701.
- Waris V, Xu JW, Nordsletten L, Sorsa S, Santavirta S, Konttinen YT. Basic fibroblast growth factor (bFGF) in the synovial- like membrane around loose total hip prostheses. Scand J Rheumatol 1996;25:257–62.
- Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131–55.
- Conover C. The Role of Insulin-Like Growth Factors and Binding Proteins in Bone Cell Biology. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology, 2ed. San Diego: Academic Press. 2002:225–37.
- Bell GI, Merryweather JP, Sanchez-Pescador R, Stempien MM, Priestley L, Scott J, et al. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984;310:775–7.
- Okazaki R, Conover CA, Harris SA, Spelsberg TC, Riggs BL. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 1995;10:788–95.
- Steenbergh PH, Koonen-Reemst AM, Cleutjens CB, Sussenbach JS. Complete nucleotide sequence of the high molecular weight human IGF-I mRNA. Biochem Biophys Res Commun 1991;175:507–14.
- Xu JW, Konttinen YT, Li TF, Waris V, Lassus J, Matucci-Cerinic M, et al. Production of platelet-derived growth factor in aseptic loosening of total hip replacement. Rheumatol Int 1998;17:215–21.